We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
-$154M
Cap. Flow
+$988M
Cap. Flow %
4.91%
Top 10 Hldgs %
28.47%
Holding
777
New
61
Increased
377
Reduced
301
Closed
33

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$252M
2
NTR icon
Nutrien
NTR
+$196M
3
B
Barrick Mining
B
+$180M
4
FNV icon
Franco-Nevada
FNV
+$165M
5
GG
Goldcorp Inc
GG
+$146M

Sector Composition

Rank Sector Weight
1 Materials 51.82%
2 Energy 17.22%
3 Healthcare 6.47%
4 Technology 5.7%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTN
701
DELISTED
Exterran Corporation
EXTN
$50K ﹤0.01%
1,881
+195
+12% +$5.64K
FLOW
702
DELISTED
SPX FLOW, Inc.
FLOW
$50K ﹤0.01%
1,007
-100
-9% -$4.87K
LKSD
703
DELISTED
LSC Communications, Inc.
LKSD
$50K ﹤0.01%
2,870
-332
-10% -$4.94K
DNOW icon
704
DNOW Inc
DNOW
$2.44B
$49K ﹤0.01%
4,801
-265
-5% -$2.89K
LITE icon
705
Lumentum
LITE
$46.9B
$48K ﹤0.01%
756
-268
-26% -$15.4K
FSCT
706
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$47K ﹤0.01%
1,449
+96
+7% +$3K
BLK icon
707
Blackrock
BLK
$167B
$44K ﹤0.01%
+82
New +$45K
FOMX
708
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$44K ﹤0.01%
8,575
+572
+7% +$3.44K
BDX icon
709
Becton Dickinson
BDX
$46.4B
$39K ﹤0.01%
+187
New +$41K
SYNH
710
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$39K ﹤0.01%
1,104
+35
+3% +$1.37K
BMO icon
711
Bank of Montreal
BMO
$123B
$34K ﹤0.01%
+446
New +$35.1K
PLUR icon
712
Pluri
PLUR
$17M
$34K ﹤0.01%
314
+21
+7% +$2.42K
STT icon
713
State Street
STT
$48.4B
$25K ﹤0.01%
+254
New +$26.6K
ECL icon
714
Ecolab
ECL
$79.8B
$24K ﹤0.01%
+178
New +$23.9K
PLD icon
715
Prologis
PLD
$136B
$23K ﹤0.01%
+366
New +$22.8K
RDHL
716
Redhill Biopharma
RDHL
$4.15M
$22K ﹤0.01%
4
BLRX
717
BioLineRX
BLRX
$12M
$21K ﹤0.01%
41
+3
+8% +$1.84K
PLX icon
718
Protalix BioTherapeutics
PLX
$183M
$20K ﹤0.01%
3,737
+249
+7% +$1.64K
PNTR
719
DELISTED
Pointer Telocation Ltd.
PNTR
$20K ﹤0.01%
1,389
+92
+7% +$1.56K
HSBC.PRA
720
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$19K ﹤0.01%
731
-352
-33% -$9.11K
CMI icon
721
Cummins
CMI
$83.6B
$18K ﹤0.01%
+108
New +$18.6K
SLF icon
722
Sun Life Financial
SLF
$45.6B
$17K ﹤0.01%
+420
New +$17.7K
ARTX
723
DELISTED
Arotech Corporation
ARTX
$17K ﹤0.01%
5,637
+376
+7% +$1.28K
A icon
724
Agilent Technologies
A
$39.6B
$15K ﹤0.01%
+220
New +$15.4K
NTRS icon
725
Northern Trust
NTRS
$21.8B
$15K ﹤0.01%
+148
New +$15.5K

Similar funds

VanEck Associates's Q1 2018 Portfolio in Review

As of Q1 2018, VanEck Associates held 777 positions worth $20.1B, down 0.76% from $20.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

VanEck Associates deployed $988M of net new capital in Q1 2018, opening 61 new positions and adding to 377 existing holdings. Its largest new stake was Nutrien: 3,920,000 shares worth $185M.

By sector, the portfolio is most concentrated in Materials at 52% of assets, up from 50% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Louisiana-Pacific, an estimated $31M trimmed.

  • VanEck Associates's largest Q1 2018 buy was Nutrien: 3,920,000 shares worth $185M.
  • VanEck Associates added most to Newmont in Q1 2018, an estimated $252M increase.
  • VanEck Associates's biggest Q1 2018 reduction was Louisiana-Pacific, cutting an estimated $31M.
  • VanEck Associates fully exited Agrium in Q1 2018, selling an estimated $169M.
  • VanEck Associates's ten largest holdings make up 28% of its $20.1B portfolio in Q1 2018.
  • VanEck Associates opened 61 new positions and closed 33 in Q1 2018.
  • VanEck Associates's portfolio value fell 0.76% quarter-over-quarter to $20.1B.

Based on VanEck Associates's 13F filing for Q1 2018, filed 11 May 2018.